Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Jinyu Bio-Technology Co's
Operating Income
for the
three
months ended in Jun. 2026 was ¥70 Mil. Jinyu Bio-Technology Co's Interest Expense for the
three
months ended in Jun. 2026 was ¥0 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Jinyu Bio-Technology Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Jinyu Bio-Technology Co's Interest Coverage or its related term are showing as below:
SHSE:600201's Interest Coverage is not ranked *
in the Biotechnology industry.
Industry Median: 98.255 * Ranked among companies with meaningful Interest Coverage only.
Jinyu Bio-Technology Co (SHSE:600201) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Jinyu Bio-Technology Co Interest Coverage Related Terms
Jinyu Bio-Technology Co Interest Coverage Historical Data
* Premium members only.
The historical data trend for Jinyu Bio-Technology Co's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
SHSE:600201 vs VRTX, REGN, MRNA: Interest Coverage Comparison
For the Biotechnology subindustry, Jinyu Bio-Technology Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jinyu Bio-Technology Co Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Jinyu Bio-Technology Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Jinyu Bio-Technology Co's Interest Coverage falls into.
Jinyu Bio-Technology Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Jinyu Bio-Technology Co (SHSE:600201) has a Interest Coverage of 0 (At Loss) as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Jinyu Bio-Technology Co and its competitors. Over the past decade, Jinyu Bio-Technology Co's Interest Coverage has ranged from 26.10 to 18,213.72. According to the industry distribution chart, Jinyu Bio-Technology Co ranks #999999 out of 370 companies in the Biotechnology industry.
Is Jinyu Bio-Technology Co's Interest Coverage too high?
Jinyu Bio-Technology Co's current Interest Coverage is 0 (At Loss). Over the past 10 years, this metric has ranged from a low of 26.10 to a high of 18,213.72. Based on the distribution chart, Jinyu Bio-Technology Co ranks #999999 out of 370 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Jinyu Bio-Technology Co has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jinyu Bio-Technology Co's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Jinyu Bio-Technology Co ranks #999999 out of 370 companies for Interest Coverage. This places Jinyu Bio-Technology Co in the lower half of its industry. The industry median Interest Coverage is 98.26. Historically, Jinyu Bio-Technology Co's own Interest Coverage has ranged from 26.10 to 18,213.72 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 98.26, based on 370 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Jinyu Bio-Technology Co and its competitors. For the Biotechnology industry, the median Interest Coverage is 98.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jinyu Bio-Technology Co's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinyu Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Jinyu Bio-Technology Co (SHSE:600201) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥9.10, compared to a current price of ¥12.32 — trading 35.4% above its estimated fair value. The current Interest Coverage is 0 (At Loss). Jinyu Bio-Technology Co's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Jinyu Bio-Technology Co (SHSE:600201), the current Interest Coverage is 0 (At Loss) as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jinyu Bio-Technology Co (SHSE:600201) Overvalued in 2026?
Based on GuruFocus' analysis, Jinyu Bio-Technology Co stock appears to be overvalued.
The current stock price of ¥12.32 is trading 35.4% above its estimated GF Value™ of ¥9.10.
GuruFocus considers Jinyu Bio-Technology Co to be Significantly Overvalued.
Key valuation signals for SHSE:600201:
Interest Coverage: 0 (At Loss)
GF Value™: ¥9.10 vs. price of ¥12.32 (35.4% above fair value)
No single metric tells the full story. See the SHSE:600201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jinyu Bio-Technology Co Ltd is engaged in the development and sales of veterinary biological products. Its products are used for pigs, poultry, pets, and ruminants.
65GF Score
Get the complete analysis for SHSE:600201
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600201 has been successfully added to your 
